Roger E. Susi, 10% Owner, Director, CEO, President, Chairman, on May 26, 2026, sold 7,500 shares in Iradimed (IRMD) for $691,044. Following the Form 4 filing with the SEC, Susi has control over a total of 2,165,000 common shares of the company, with 2,165,000 controlled indirectly.
SEC Filing:
Price: $91.99, Change: $+0.15, Percent Change: +0.16%